| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex®): A Review in Multiple Sclerosis-Related Spasticity
|
Keating, Gillian M.
|
|
2017
|
77 |
5 |
p. 563-574
|
artikel
|
| 2 |
Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema
|
Syed, Yahiya Y.
|
|
2017
|
77 |
5 |
p. 575-583
|
artikel
|
| 3 |
Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis
|
Geloneze, Bruno
|
|
2017
|
77 |
5 |
p. 493-503
|
artikel
|
| 4 |
Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience
|
Holstein, Sarah A.
|
|
2017
|
77 |
5 |
p. 505-520
|
artikel
|
| 5 |
JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
|
Banerjee, Shubhasree
|
|
2017
|
77 |
5 |
p. 521-546
|
artikel
|
| 6 |
JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
|
Banerjee, Shubhasree
|
|
|
77 |
5 |
p. 521-546
|
artikel
|
| 7 |
Plecanatide: First Global Approval
|
Al-Salama, Zaina T.
|
|
2017
|
77 |
5 |
p. 593-598
|
artikel
|
| 8 |
Rucaparib: First Global Approval
|
Syed, Yahiya Y.
|
|
2017
|
77 |
5 |
p. 585-592
|
artikel
|
| 9 |
Therapeutic Options in Refractory Diabetic Macular Oedema
|
Shah, Sanket U.
|
|
2017
|
77 |
5 |
p. 481-492
|
artikel
|
| 10 |
Therapeutic Options in Refractory Diabetic Macular Oedema
|
Shah, Sanket U.
|
|
|
77 |
5 |
p. 481-492
|
artikel
|
| 11 |
The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus
|
Johnson, David A.
|
|
2017
|
77 |
5 |
p. 547-561
|
artikel
|
Tijdschrift beschrijving